Immix Biopharma Inc
(IMMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 598 | 348 | 243 | 163 | 0 |
| Operating Income | -598 | -348 | -243 | -163 | N/A |
| Interest Expense | 45 | 54 | 54 | 28 | 0 |
| Other Income | -22,111 | 0 | 90 | -825 | 0 |
| Pre-tax Income | -22,754 | -402 | -207 | -1,015 | 0 |
| Income Tax | 2 | 1 | 2 | 2 | N/A |
| Net Income Continuous | -22,755 | -403 | -209 | -1,017 | N/A |
| Net Income | $-22,755 | $-403 | $-209 | $-1,017 | $N/A |
| EPS Basic Total Ops | -6.16 | -0.12 | -0.06 | -0.30 | N/A |
| EPS Basic Continuous Ops | -6.16 | -0.12 | -0.06 | -0.30 | N/A |
| EPS Diluted Total Ops | -6.16 | -0.12 | -0.06 | -0.30 | N/A |
| EPS Diluted Continuous Ops | -6.16 | -0.12 | -0.06 | -0.30 | N/A |
| EBITDA(a) | $-581 | $-327 | $-223 | $-160 | $N/A |